Rapid Relapse of Idiopathic Multicentric Castleman Disease After Siltuximab Discontinuation in a Case with Complete Remission for More Than 10 Years

Turk J Haematol. 2024 Dec 2;41(4):283-285. doi: 10.4274/tjh.galenos.2024.2024.0339. Epub 2024 Nov 6.
No abstract available

Keywords: Siltuximab; Idiopathic multicentric Castleman disease; Relapse; Discontinuation.